학술논문
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
Document Type
Article
Author
Ghilardi, G.; Gerson, J.N.; Paruzzo, L.; Chong, E.A.; Svoboda, J.; Nasta, S.D.; Ugwuanyi, O.H.; Landsburg, D.J.; Fardella, E.; Chong, E.R.; Patel, V.; Pajarillo, R.; Barta, S.K.; Schuster, S.J.; Ruella, M.; Fraietta, J.A.; Susanibar Adaniya, S.P.; Waxman, A.J.; Kulikovskaya, I.; Cohen, A.D.; Levine, B.L.; Stadtmauer, E.A.; Frey, N.V.; Vogl, D.T.; Hexner, E.O.; Porter, D.L.; Garfall, A.L.; June, C.H.; Van Deerlin, V.M.; Morrissette, J.J.D.; Caponetti, G.C.; Harris, J.C.; Lieberman, D.B.
Source
In: Nature Medicine . (Nature Medicine, April 2024, 30(4):984-989)
Subject
Language
English
ISSN
1546170X
10788956
10788956